SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-044971
Filing Date
2019-12-02
Accepted
2019-12-02 07:52:08
Documents
8
Period of Report
2019-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K NBIX LICENSE AGREEMENT xene-8k_20191202.htm 8-K 73494
2 EX-10.1 xene-ex101_6.htm EX-10.1 1372526
3 EX-10.2 xene-ex102_33.htm EX-10.2 174086
4 EX-99.1 xene-ex991_114.htm EX-99.1 36326
5 GRAPHIC gcta0gmba3ia000001.jpg GRAPHIC 2933
6 GRAPHIC grvx1qn4ttoy000002.jpg GRAPHIC 13001
7 GRAPHIC gcta0gmba3ia000002.jpg GRAPHIC 2101
8 GRAPHIC grvx1qn4ttoy000001.jpg GRAPHIC 4770
  Complete submission text file 0001564590-19-044971.txt   1689705
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 191262074
SIC: 2834 Pharmaceutical Preparations